{'fraction_non_alphanumeric': 0.01877133105802048, 'fraction_numerical': 0.017918088737201365, 'mean_word_length': 5.780346820809249, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 1, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Gastrointestinal biodurability of engineered nanoparticles: Development of an in vitro assay

The toxicity of engineered nanoparticles is expected to depend in part on their stability in biological systems. To assess the biodurability of engineered nanomaterials in the human digestive system, we adapted an in vitro assay previously used to evaluate the bioaccessibility of metals in contaminated soils. The compositions of the simulated gastric and intestinal fluids, temperature and residence times were designed to closely mimic conditions in the stomach and duodenum of the small intestine. We demonstrated the utility of the assay using CdSecore/ZnSshell quantum dots functionalized with polyethylene glycol (PEG) thiol of two different molecular masses (PEG350 and PEG5000). Under gastric conditions, removal of the PEG ligand diminished the stability of PEG350-quantum dot suspensions, while PEG5000-quantum dots were severely degraded. Inclusion of the glycoprotein mucin, but not the digestive protein pepsin, in simulated gastric fluids provided both PEG350- and PEG5000-coated quantum dots partial protection from transformations induced by gastric conditions.